about
Sleep disruption and the sequelae associated with traumatic brain injuryDeconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purposeNonpharmacological treatments for patients with Parkinson's disease.Efficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studies.Measurement of Voluntary Cough Production and Airway Protection in Parkinson DiseaseNurr1-Based Therapies for Parkinson's Disease.Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson's Disease.Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders.Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.Parkinson's disease, antiparkinson medicines, and driving.Opicapone: A Review in Parkinson's Disease.Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.Trajectories of prediagnostic functioning in Parkinson's disease.The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease.Severely Affected by Parkinson Disease: The Patient's View and Implications for Palliative Care.Inhibiting Basal Ganglia Regions Reduces Syllable Sequencing Errors in Parkinson's Disease: A Computer Simulation Study.
P2860
Q23910486-9D8FCEE5-DDD8-4CDD-8D45-03424A5FB679Q26785491-4F55BC4E-583E-4ECD-A053-BAF6D77F1E1BQ30377906-9B431600-3780-4D0D-8FEC-453ADCEB65C4Q31060186-9D6D124A-4068-4030-BF5E-93B8C2011627Q36626869-643369B3-6B13-4E11-AEB7-201486E625DDQ36803630-B5A62259-84A2-43DF-8121-9F11A2648B3DQ36925905-2C9F2F6A-BFDA-4033-9955-FA8584E045B0Q37351959-511FED2E-D83D-4DEE-BD59-C58BBDF703B0Q37512670-B591407B-3F55-422F-8DF6-975E88CDA5ACQ38588201-5EC40201-461C-4FCB-A4F4-BBBECBB62E2DQ38701175-A8BE0C93-A416-4E83-BD5A-CAEB2036856AQ38910199-724404E3-AB99-4BBE-A41E-4D8C5656D2D6Q38920856-E6B5EACA-F2F6-4FD6-8B74-A4432F9725F7Q39119095-5543C49C-7BA4-4B04-B542-2438179CE882Q40383022-82E72824-0D2B-4E25-AE02-505518257555Q41913461-C4569639-257D-430E-8EDD-5EAB10E65ABCQ47767613-B583CEA4-BCFC-4763-8DB4-5D5C699ACE0DQ55469336-64A66426-ABD3-42E7-9E18-1E953AD68B00
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Initial management of Parkinson's disease
@ast
Initial management of Parkinson's disease
@en
Initial management of Parkinson's disease
@nl
type
label
Initial management of Parkinson's disease
@ast
Initial management of Parkinson's disease
@en
Initial management of Parkinson's disease
@nl
prefLabel
Initial management of Parkinson's disease
@ast
Initial management of Parkinson's disease
@en
Initial management of Parkinson's disease
@nl
P3181
P356
P1433
P1476
Initial management of Parkinson's disease
@en
P2093
P3181
P356
10.1136/BMJ.G6258
P407
P433
P577
2014-12-19T00:00:00Z